These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 1619004)
1. Effects of systemic growth hormone (GH) administration on regional adipose tissue in children with non-GH-deficient short stature. Rosenbaum M; Gertner JM; Gidfar N; Hirsch J; Leibel RL J Clin Endocrinol Metab; 1992 Jul; 75(1):151-6. PubMed ID: 1619004 [TBL] [Abstract][Full Text] [Related]
2. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. Rosenbaum M; Gertner JM; Leibel RL J Clin Endocrinol Metab; 1989 Dec; 69(6):1274-81. PubMed ID: 2685009 [TBL] [Abstract][Full Text] [Related]
3. Regional differences in adrenoreceptor status of adipose tissue in adults and prepubertal children. Rosenbaum M; Presta E; Hirsch J; Leibel RL J Clin Endocrinol Metab; 1991 Aug; 73(2):341-7. PubMed ID: 1649839 [TBL] [Abstract][Full Text] [Related]
4. Human growth hormone treatment of short-stature children born small for gestational age: effect on muscle and adipose tissue mass during a 3-year treatment period and after 1 year's withdrawal. Leger J; Garel C; Fjellestad-Paulsen A; Hassan M; Czernichow P J Clin Endocrinol Metab; 1998 Oct; 83(10):3512-6. PubMed ID: 9768656 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone therapy in short children born small for gestational age: effects on abdominal fat partitioning and circulating follistatin and high-molecular-weight adiponectin. Ibáñez L; Lopez-Bermejo A; Díaz M; Jaramillo A; Marín S; de Zegher F J Clin Endocrinol Metab; 2010 May; 95(5):2234-9. PubMed ID: 20332245 [TBL] [Abstract][Full Text] [Related]
6. Body composition, blood pressure, and lipid metabolism before and during long-term growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. Sas T; Mulder P; Hokken-Koelega A J Clin Endocrinol Metab; 2000 Oct; 85(10):3786-92. PubMed ID: 11061539 [TBL] [Abstract][Full Text] [Related]
7. Improved adipose tissue metabolism after 5-year growth hormone replacement therapy in growth hormone deficient adults: The role of zinc-α2-glycoprotein. Balaž M; Ukropcova B; Kurdiova T; Vlcek M; Surova M; Krumpolec P; Vanuga P; Gašperíková D; Klimeš I; Payer J; Wolfrum C; Ukropec J Adipocyte; 2015; 4(2):113-22. PubMed ID: 26167410 [TBL] [Abstract][Full Text] [Related]
8. Site- and sex-related differences in adrenoreceptor status of human adipose tissue. Leibel RL; Hirsch J J Clin Endocrinol Metab; 1987 Jun; 64(6):1205-10. PubMed ID: 3571424 [TBL] [Abstract][Full Text] [Related]
10. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518 [TBL] [Abstract][Full Text] [Related]
11. High-dose growth hormone treatment of short children born small for gestational age. de Zegher F; Maes M; Gargosky SE; Heinrichs C; Du Caju MV; Thiry G; De Schepper J; Craen M; Breysem L; Löfström A; Jönsson P; Bourguignon JP; Malvaux P; Rosenfeld RG J Clin Endocrinol Metab; 1996 May; 81(5):1887-92. PubMed ID: 8626853 [TBL] [Abstract][Full Text] [Related]
12. Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. Roemmich JN; Huerta MG; Sundaresan SM; Rogol AD Metabolism; 2001 May; 50(5):537-47. PubMed ID: 11319714 [TBL] [Abstract][Full Text] [Related]
13. Lack of beta 3-adrenergic effect on lipolysis in human subcutaneous adipose tissue. Rosenbaum M; Malbon CC; Hirsch J; Leibel RL J Clin Endocrinol Metab; 1993 Aug; 77(2):352-5. PubMed ID: 8393882 [TBL] [Abstract][Full Text] [Related]
14. Growth hormone (GH) treatment in short normal children: absence of influence of time of injection and resistance to GH autofeedback. Chanoine JP; Vanderschueren-Lodeweyckx M; Maes M; Thiry-Counson G; Craen M; Van Vliet G J Clin Endocrinol Metab; 1991 Dec; 73(6):1269-75. PubMed ID: 1955508 [TBL] [Abstract][Full Text] [Related]
15. Growth hormone treatment in adolescent males with idiopathic short stature: changes in body composition, protein, fat, and glucose metabolism. Hannon TS; Danadian K; Suprasongsin C; Arslanian SA J Clin Endocrinol Metab; 2007 Aug; 92(8):3033-9. PubMed ID: 17519313 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk score is linked to subcutaneous adipocyte size and lipid metabolism. Rydén M; Arner P J Intern Med; 2017 Sep; 282(3):220-228. PubMed ID: 28635127 [TBL] [Abstract][Full Text] [Related]
17. The regulation of adipose tissue distribution in humans. Björntorp P Int J Obes Relat Metab Disord; 1996 Apr; 20(4):291-302. PubMed ID: 8680455 [TBL] [Abstract][Full Text] [Related]
18. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. Pasquino AM; Pucarelli I; Roggini M; Segni M J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865 [TBL] [Abstract][Full Text] [Related]
19. Subcutaneous growth hormone-releasing hormone therapy in growth hormone-deficient children: first year of therapy. Duck SC; Schwarz HP; Costin G; Rapaport R; Arslanian S; Hayek A; Connors M; Jaramillo J J Clin Endocrinol Metab; 1992 Oct; 75(4):1115-20. PubMed ID: 1400880 [TBL] [Abstract][Full Text] [Related]
20. Lipid patterns in treated growth hormone deficient children vs. short stature controls. Foster C; Burton A; Scholl J; Scott ML; Gunter V; McCormick K J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):909-14. PubMed ID: 24859507 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]